American Portfolios Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

American Portfolios Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-73	Closed	-$3.65K	–	3641
2022 Q1	$3.65K	Hold	73	–	–	﹤0.01%	3049
2021 Q4	$5.15K	Sell	73 -20	-22%	-$1.69K	﹤0.01%	2879
2021 Q3	$8.71K	Sell	93 -17	-15%	-$1.61K	﹤0.01%	2623
2021 Q2	$11.1K	Sell	110 -17	-13%	-$1.66K	﹤0.01%	2473
2021 Q1	$11.8K	Hold	127	–	–	﹤0.01%	2304
2020 Q4	$10.4K	Hold	127	–	–	﹤0.01%	2089
2020 Q3	$10.9K	Buy	+127	New	+$14.8K	﹤0.01%	1952

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

American Portfolios Advisors's VBIV Position: Q2 2022 in Review

American Portfolios Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2022, closing a stake of 73 shares — an estimated $3.65K sold.

American Portfolios Advisors first reported a position in VBIV in Q3 2020 and held it in 7 quarters. The position peaked at $11.8K in Q1 2021. 130 funds tracked by Wall St. Rank hold VBIV as of Q2 2022.

American Portfolios Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2022 after selling out during the quarter.
American Portfolios Advisors sold 73 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2022, an estimated $3.65K.
American Portfolios Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2020 and held it in 7 quarters.
American Portfolios Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $11.8K in Q1 2021.
130 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2022.

Based on American Portfolios Advisors's 13F filing for Q2 2022, filed 20 Mar 2023.